Ketchem Corey J, Reed Craig C, Dellon Evan S
Center for Esophageal Diseases and Swallowing, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Division of Gastroenterology and Hepatology, Department of Medicine, Hospital of the University of Pennsylvania,. Philadelphia, PA, USA.
Am J Gastroenterol. 2024 Sep 1;119(9):1813-1820. doi: 10.14309/ajg.0000000000002869. Epub 2024 May 16.
It is unknown whether concomitant esophageal involvement or anatomic location of eosinophilic infiltration affects the natural history of eosinophilic gastrointestinal disease (EGID).
A retrospective cohort study was performed using the University of North Carolina EGID Clinicopathologic Database. Patients were adults and children with a prior EGID diagnosis based on clinicopathologic features. Demographics, clinical characteristics, treatment information, and procedural data were extracted from medical records. Clinical course and flare history were characterized.
Among 97 patients, 43% had EGID + esophageal involvement and 57% had EGID only. Patients with esophageal involvement had a longer diagnostic delay preceding diagnosis (36.6 vs 11.6 months, P = 0.001), more dysphagia (50% vs 18%; P = 0.001), required more chronic therapy (77% vs 52%, P = 0.016), and exhibited more progressive disease (25% vs 6%, P = 0.027). A continuous disease course was most common in eosinophilic gastritis (78%) while patients with eosinophilic gastritis + eosinophilic enteritis (29%) and eosinophilic enteritis + eosinophilic colitis (50%) had the highest proportion of progressive and relapsing disease, respectively ( P = 0.045). A continuous disease course occurred more frequently in children (71%, P = 0.03) and those with single organ involvement (65%), whereas adults had more relapsing (39%) or progressive disease (18%).
EGIDs with and without esophageal involvement display many similarities, although patients with esophageal involvement more frequently had dysphagia, had progressive disease courses, and required more chronic therapy. Location of involvement and age of onset affected the natural history with higher proportions of relapsing or progressive disease seen in adults and patients with small bowel or multiorgan involvement while a continuous disease course was more common in children and patients with gastric-only involvement.
嗜酸性粒细胞性胃肠道疾病(EGID)患者是否合并食管受累或嗜酸性粒细胞浸润的解剖位置是否会影响其疾病自然史尚不清楚。
利用北卡罗来纳大学EGID临床病理数据库进行一项回顾性队列研究。患者包括基于临床病理特征先前已诊断为EGID的成人和儿童。从病历中提取人口统计学、临床特征、治疗信息和手术数据。对临床病程和病情复发史进行了描述。
97例患者中,43%合并EGID +食管受累,57%仅患有EGID。食管受累患者在确诊前的诊断延迟时间更长(36.6个月对11.6个月,P = 0.001),吞咽困难更多见(50%对18%;P = 0.001),需要更多的长期治疗(77%对52%,P = 0.016),且疾病进展更明显(25%对6%,P = 0.027)。持续性病程在嗜酸性粒细胞性胃炎中最为常见(78%),而嗜酸性粒细胞性胃炎 + 嗜酸性粒细胞性肠炎患者(29%)和嗜酸性粒细胞性肠炎 + 嗜酸性粒细胞性结肠炎患者(50%)的疾病进展和复发比例分别最高(P = 0.045)。持续性病程在儿童(71%,P = 0.03)和单器官受累患者(65%)中更常见,而成人复发(39%)或疾病进展(18%)的情况更多。
合并或未合并食管受累的EGID表现出许多相似之处,尽管食管受累患者更常出现吞咽困难、疾病呈进行性病程且需要更多的长期治疗。受累部位和发病年龄影响疾病自然史,成人以及小肠或多器官受累患者的疾病复发或进展比例更高,而持续性病程在儿童和仅胃部受累的患者中更常见。